Ki67 Changes And Pepi Score In The Lorelei Trial: A Phase Ii Randomized, Double-Blind Study Of Neoadjuvant Letrozole Plus Taselisib Versus Letrozole Plus Placebo In Postmenopausal Women With Er-Positive/Her2-Negative Early-Stage Breast Cancer
CANCER RESEARCH(2018)
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined